Ikegame Kazuhiro

イケガメカズヒロ | Ikegame Kazuhiro

Affiliation and department：
Job title： Professor

Research field (1)： Hematology and oncology

Research keywords (4)：造血細胞移植 , 自己免疫 , 移植免疫 , 腫瘍免疫

Research theme for competitive and other funds (12)：

2021 - 2024 Are there T cells restricted with unshared HLA between patient and donor in HLA haploidentical transplantation?
2020 - 2023 Communication and supportive care in adolescent and young adult with hematologic malignancy
2018 - 2021 Immune-escape mechanism of relapsed leukemic cells after multiple transplantation
2017 - 2020 同種造血幹細胞移植患者における、ステロイド抵抗性/依存性腸管急性移植片対宿主病(GVHD)に対する便微生物移植(fecal microbiota transplantation)の有効性を検討する第II相多施設共同研究
2016 - 2019 Novel therapeutic strategy by intrabone marrow co-transplantation of cord blood and cord-derived mesenchymal stem cells

Show all

Papers (202)：

Kazuhiro Ikegame. CAR-T Therapy can be a Useful Treatment Modality for more than Just Hematologic Malignancies. Internal medicine (Tokyo, Japan). 2024
Kazuhiro Ikegame, Keiko Fukunaga, Yuko Osugi, Katsuji Kaida, Masahiro Teramoto, Takayuki Inoue, Masaya Okada, Kyoko Yoshihara, Hiroya Tamaki, Satoshi Yoshihara, et al. Donor-derived cytomegalovirus-specific CD8+ T cells restricted to shared, donor-specific, or host-specific HLA after HLA mismatched hematopoietic stem cell transplantation. Transplant immunology. 2024. 102099-102099
Yoshihiro Inamoto, Koji Kato, Toshiro Kawakita, Yasushi Onishi, Ken-Ichi Matsuoka, Soichi Shiratori, Kazuhiro Ikegame, Nobuhiro Hiramoto, Masako Toyosaki, Yuta Katayama, et al. An open-label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid-dependent/steroid-resistant chronic GVHD. American journal of hematology. 2024
Yachiyo Kuwatsuka, Hidemi Ito, Ken Tabuchi, Takaaki Konuma, Naoyuki Uchida, Yoshihiro Inamoto, Kazuki Inai, Tetsuya Nishida, Kazuhiro Ikegame, Tetsuya Eto, et al. Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data. Bone marrow transplantation. 2024
Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, Hirohito Yamazaki, Takehiko Mori, Naoyuki Uchida, Noriko Doki, Jun Kato, Masashi Nishikubo, Shinichi Kako, et al. Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation. Bone marrow transplantation. 2024. 59. 5. 688-691

ｍore...

MISC (90)：

岡村浩史, 岡村浩史, 中前博久, 中前美佳, 中前美佳, 加葉田大志朗, 吉田寿子, 新谷歩, 内田直之, 土岐典子, et al. Personalized transplant strategy guided by machine learning in allogeneic stem cell transplantation. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
吉原享子, 吉原哲, 吉原哲, 星山季子, 熊本友子, 佐守真実, 宇都宮惟人, 藤田佳之, 前田冬樹, 池本純子, et al. Prognosis after CAR T-cell therapy for relapse/refractory DLBCL. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
吉原哲, 吉原哲, 吉原享子, 佐守真実, 宇都宮惟人, 平田早希, 池本純子, 福永景子, 海田勝仁, 池亀和博, et al. CAR T-cell therapy for relapse/refractory DLBCL: a single center experience. 日本血液学会学術集会抄録(Web). 2021. 83rd
鍬塚八千代, 伊藤秀美, 田渕健, 小沼貴晶, 内田直之, 土岐典子, 小澤幸泰, 池亀和博, 福田隆浩, 一戸辰夫, et al. Net survival and conditional survival after allogeneic HSCT: Japanese transplant registry analysis. 日本造血細胞移植学会総会プログラム・抄録集. 2021. 43rd
原田介斗, 藤重夫, 木村俊一, 名島悠峰, 薬師神公和, 内田直之, 鬼塚真仁, 池亀和博, 矢野真吾, 土岐典子, et al. Prognostic scoring system for patients undergoing salvage transplantation for graft failure. 日本造血細胞移植学会総会プログラム・抄録集. 2021. 43rd

ｍore...

Books (1)：

生存時間データ解析 : Cox比例ハザードモデルからディープラーニングまで
共立出版 2024 ISBN:9784320115637

Professional career (1)：

医学博士 (大阪大学)

Work history (1)：

2024/05 - 現在 Aichi Medical University Hematopoietic Cell Transplantation Center Professor

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page